Breaking News

Alliance for Hippocratic Medicine v. Food and Drug Administration

Petition for certiorari denied on December 13, 2023
Docket No. Op. Below Argument Opinion Vote Author Term
23-395 5th Cir. N/A N/A N/A N/A OT 2023

Issue: (1) Whether the Alliance's challenge to the Food and Drug Administration’s 2000 mifepristone approval is timely; and (2) whether FDA’s 2000 approval of mifepristone under 21 C.F.R. 314.500, which applies only to drugs that “treat[ ] serious or life-threatening illnesses,” and FDA’s subsequent approval of generic mifepristone were unlawful.

SCOTUSblog Coverage

DateProceedings and Orders (key to color coding)
Oct 12 2023Petition for a writ of certiorari filed. (Response due November 15, 2023)
Nov 07 2023Brief of respondent Danco Laboratories, LLC in opposition filed.
Nov 07 2023Brief of Federal Cross-Respondents in opposition filed.
Nov 13 2023Brief amici curiae of Mississippi, et al. filed.
Nov 15 2023Brief amicus curiae of Human Coalition filed.
Nov 15 2023Brief amici curiae of 109 Members of Congress filed.
Nov 15 2023Amicus brief of 109 Members of Congress not accepted for filing. (February 09, 2024 -- Duplicate submission)
Nov 21 2023DISTRIBUTED for Conference of 12/8/2023.
Nov 28 2023Reply of petitioners Alliance for Hippocratic Medicine, et al. filed. (Distributed)
Dec 13 2023Petition DENIED.